Gemini Staffing Consultants

We provide the personnel assets that allow for successful site selections, initiations, and closeouts. Gemini Staffing’s contractual field monitors are paid on a weekly basis and are deployed anywhere from 3-24 months per assignment.

Gemini maintains a very specific and definitive focus on these fields, and this deep knowledge and experience enables our clients and candidates to reap maximum benefits in conducting successful clinical trials.

We leverage our large network of industry professionals with a team-based approach, allowing us a high degree of responsiveness and flexibility to identify and provide the right personnel at the right time, to help you reach your goals.

We pre-screen all candidates based on your requirements, and present quality personnel. Our approach has always been quality over quantity, thereby saving you time.

Smaller emerging companies are seeing big gains, and Gemini excels in providing crucial, customized on-demand clinical staffing resources that land within budget and timeline requirements. 

Our approach is team-based, and it allows us to be proactive and flexible for our clients, especially when paired with our large national network of industry professionals.

Gemini draws from a nationwide network of professionals. We maintain a process, approach, professionalism and level of integrity important to delivering results and keeping our clients wholly satisfied, and in position for success.

As the staffing partner of choice for many in the life sciences industry, we aim to leave both clients and candidates wholly satisfied with our process, approach, professionalism and, most importantly, our level of integrity. It has always been our belief that results will follow if we adhere to these four core concepts, and our […]

Breakthrough Therapy Designation further supports the differentiated clinical profile of CLN-081. Click link below to read press release. Source: https://investors.cullinanoncology.com/news-releases/news-release-details/fda-grants-breakthrough-therapy-designation-cullinan-oncologys